ARCHIVES

Nine New Grants Awarded In The NCI “Director’s Challenge”.

This article is from The Cancer Letter archive.

Vol. 26 No. 37 | October 13, 2000

Download PDF Visit The Full Archive

Related Articles

Carfilzomib Demonstrates Clinical Benefit Rate of 64%

December 30, 2011

UC Davis Is U.S. Site For Trial Of Exemestane For Breast Ca.

September 24, 2004

DCT Board Sends Message On Cutting Grants to Extend Paylines, Then Tries To Take It Back

March 2, 1984

May issue of Business & Regulatory Report, 8 additional pages, included.

May 28, 2004

Also: NCCN Committee Reaffirms Clinical Guideline Covering Avastin for Breast Cancer Indication

July 22, 2011

Appropriations 2014: Obama Plan Good News for NIH, Bad News For Some Oncologists

April 12, 2013